Prion and Nonprion Amyloids

References

• Horwich AL, Weissman JS. Deadly conformations—Protein misfolding in prion disease. Cell 1997; 89:499 - 510
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell 1998; 93:337 - 348
   PubMed Web of Science ®Google Scholar
• Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 2006; 75:333 - 366
   PubMed Web of Science ®Google Scholar
• Fowler DM, Koulov AV, Alory-Jost C, Marks MS, Balch WE, Kelly JW. Functional amyloid formation within mammalian tissue. PLoS Biol 2005; 4:e6
   Web of Science ®Google Scholar
• Si K, Lindquist S, Kandel ER. A neuronal isoform of the Aplysia CPEB has prion-like properties. Cell 2003; 115:879 - 891
   PubMed Web of Science ®Google Scholar
• Wickner RB. [URE3] as an altered Ure2 protein: Evidence for a prion analog in Saccharomyces cerevisiae. Science 1994; 264:566 - 569
   PubMed Web of Science ®Google Scholar
• Coustou V, Deleu C, Saupe SJ, Begueret J. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc Natl Acad Sci USA 1997; 94:9773 - 9778
   PubMed Web of Science ®Google Scholar
• Derkatch IL, Bradley ME, Zhou P, Chernoff YO, Liebman SW. Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae. Genetics 1997; 147:507 - 519
   PubMed Web of Science ®Google Scholar
• Bradley ME, Edskes HK, Hong JY, Wickner RB, Liebman SW. Interactions among prions and prion “strains” in yeast. Proc Natl Acad Sci USA 2002; 99:Suppl 4 16392 - 16399
   PubMed Web of Science ®Google Scholar
• Sondheimer N, Lindquist S. Rnq1: An epigenetic modifier of protein function in yeast. Mol Cell 2000; 5:163 - 172
   PubMed Web of Science ®Google Scholar
• Santoso A, Chien P, Osherovich LZ, Weissman JS. Molecular basis of a yeast prion species barrier. Cell 2000; 100:277 - 288
   PubMed Web of Science ®Google Scholar
• Derkatch IL, Bradley ME, Hong JY, Liebman SW. Prions affect the appearance of other prions: The story of [PIN+]. Cell 2001; 106:171 - 182
   PubMed Web of Science ®Google Scholar
• Ter-Avanesyan MD, Dagkesamanskaya AR, Kushnirov VV, Smirnov VN. The SUP35 omnipotent suppressor gene is involved in the maintenance of the nonmendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics 1994; 137:671 - 676
   PubMed Web of Science ®Google Scholar
• Derkatch IL, Chernoff YO, Kushnirov VV, Inge-Vechtomov SG, Liebman SW. Genesis and variability of [PSI+] prion factors in Saccharomyces cerevisiae. Genetics 1996; 144:1375 - 1386
   PubMed Web of Science ®Google Scholar
• Liu JJ, Sondheimer N, Lindquist SL. Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+]. Proc Natl Acad Sci USA 2002; 99:16446 - 16453
   PubMed Web of Science ®Google Scholar
• Bradley ME, Liebman SW. The Sup35 domains required for maintenance of weak, strong or undifferentiated yeast [PSI+] prions. Mol Microbiol 2004; 51:1649 - 1659
   PubMed Web of Science ®Google Scholar
• Ter-Avanesyan MD, Kushnirov VV, Dagkesamanskaya AR, Didichenko SA, Chernoff YO, Inge-Vechtomov SG, Smirnov VN. Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two nonoverlapping functional regions in the encoded protein. Mol Microbiol 1993; 7:683 - 692
   PubMed Web of Science ®Google Scholar
• Zhou P, Derkatch IL, Uptain SM, Patino MM, Lindquist S, Liebman SW. The yeast nonmendelian factor [ETA+] is a variant of [PSI+], a prion-like form of release factor eRF3. EMBO J 1999; 18:1182 - 1191
   PubMed Web of Science ®Google Scholar
• Kochneva-Pervukhova NV, Chechenova MB, Valouev IA, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD. [PSI+] prion generation in yeast: Characterization of the “strain” difference. Yeast 2001; 18:489 - 497
   PubMed Web of Science ®Google Scholar
• Coschigano PW, Magasanik B. The URE2 gene product of Saccharomyces cerevisiae plays an important role in the cellular response to the nitrogen source and has homology to glutathione S-transferases. Mol Cell Biol 1991; 11:822 - 832
   PubMed Web of Science ®Google Scholar
• Patino MM, Liu JJ, Glover JR, Lindquist S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 1996; 273:622 - 626
   PubMed Web of Science ®Google Scholar
• Glover JR, Kowal AS, Schirmer EC, Patino MM, Liu JJ, Lindquist S. Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae. Cell 1997; 89:811 - 819
   PubMed Web of Science ®Google Scholar
• King CY, Tittmann P, Gross H, Gebert R, Aebi M, Wüthrich K. Prion-inducing domain 2–114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc Natl Acad Sci USA 1997; 94:6618 - 6622
   PubMed Web of Science ®Google Scholar
• Derkatch IL, Uptain SM, Outeiro TF, Krishnan R, Lindquist SL, Liebman SW. Effects of Q/N-rich, polyQ, and nonpolyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Proc Natl Acad Sci USA 2004; 101:12934 - 12939
   PubMed Web of Science ®Google Scholar
• King CY, Diaz-Avalos R. Protein-only transmission of three yeast prion strains. Nature 2004; 428:319 - 323
   PubMed Web of Science ®Google Scholar
• Tanaka M, Chien P, Naber N, Cooke R, Weissman JS. Conformational variations in an infectious protein determine prion strain differences. Nature 2004; 428:323 - 328
   PubMed Web of Science ®Google Scholar
• Brachmann A, Baxa U, Wickner RB. Prion generation in vitro: Amyloid of Ure2p is infectious. EMBO J 2005; 24:3082 - 3092
   PubMed Web of Science ®Google Scholar
• Kryndushkin DS, Alexandrov IM, Ter-Avanesyan MD, Kushnirov VV. Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J Biol Chem 2003; 278:49636 - 49643
   PubMed Web of Science ®Google Scholar
• Bagriantsev S, Liebman SW. Specificity of prion assembly in vivo: [PSI+] and [PIN+] form separate structures in yeast. J Biol Chem 2004; 279:51042 - 51048
   PubMed Web of Science ®Google Scholar
• Jones GW, Tuite MF. Chaperoning prions: The cellular machinery for propagating an infectious protein?. Bioessays 2005; 27:823 - 832
   PubMed Web of Science ®Google Scholar
• Chernoff YO, Lindquist SL, Ono B, et al. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [PSI+]. Science 1995; 268:880 - 884
   PubMed Web of Science ®Google Scholar
• Moriyama H, Edskes HK, Wickner RB. [URE3] prion propagation in Saccharomyces cerevisiae: Requirement for chaperone Hsp104 and curing by overexpressed chaperone Ydj1p. Mol Cell Biol 2000; 20:8916 - 8922
   PubMed Web of Science ®Google Scholar
• Parsell DA, Kowal AS, Singer MA, Lindquist S. Protein disaggregation mediated by heat-shock protein Hsp104. Nature 1994; 372:475 - 478
   PubMed Web of Science ®Google Scholar
• Glover JR, Lindquist S. Hsp104, Hsp70, and Hsp40: A novel chaperone system that rescues previously aggregated proteins. Cell 1998; 94:73 - 82
   PubMed Web of Science ®Google Scholar
• Kushnirov VV, Ter-Avanesyan MD. Structure and replication of yeast prions. Cell 1998; 94:13 - 16
   PubMed Web of Science ®Google Scholar
• Serio TR, Cashikar AG, Kowal AS, Sawicki GJ, Moslehi JJ, Serpell L, Arnsdorf MF, Lindquist SL. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 2000; 289:1317 - 1321
   PubMed Web of Science ®Google Scholar
• Ferreira PC, Ness F, Edwards SR, Cox BS, Tuite MF. The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol Microbiol 2001; 40:1357 - 1369
   PubMed Web of Science ®Google Scholar
• Tuite MF, Mundy CR, Cox BS. Agents that cause a high frequency of genetic change from [PSI+] to [psi-] in Saccharomyces cerevisiae. Genetics 1981; 98:691 - 711
   PubMed Web of Science ®Google Scholar
• Eaglestone SS, Ruddock LW, Cox BS, Tuite MF. Guanidine hydrochloride blocks a critical step in the propagation of the prion-like determinant [PSI+] of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 2000; 97:240 - 244
   PubMed Web of Science ®Google Scholar
• Ness F, Ferreira P, Cox BS, Tuite MF. Guanidine hydrochloride inhibits the generation of prion “seeds” but not prion protein aggregation in yeast. Mol Cell Biol 2002; 22:5593 - 5605
   PubMed Web of Science ®Google Scholar
• Jung G, Jones G, Masison DC. Amino acid residue 184 of yeast Hsp104 chaperone is critical for prion-curing by guanidine, prion propagation, and thermotolerance. Proc Natl Acad Sci USA 2002; 99:9936 - 9941
   PubMed Web of Science ®Google Scholar
• Kushnirov VV, Kochneva-Pervukhova NV, Chechenova MB, Frolova NS, Ter-Avanesyan MD. Prion properties of the Sup35 protein of yeast Pichia methanolica. EMBO J 2000; 19:324 - 3231
   PubMedGoogle Scholar
• Schlumpberger M, Prusiner SB, Herskowitz I. Induction of distinct [URE3] yeast prion strains. Mol Cell Biol 2001; 21:7035 - 7046
   PubMed Web of Science ®Google Scholar
• Kushnirov VV, Kryndushkin DS, Boguta M, et al. Chaperones that cure yeast artificial [PSI+] and their prion-specific effects. Curr Biol 2000; 10:1443 - 1446
   PubMed Web of Science ®Google Scholar
• King CY. Supporting the structural basis of prion strains: Induction and identification of [PSI+] variants. J Mol Biol 2001; 307:1247 - 1260
   PubMed Web of Science ®Google Scholar
• Krishnan R, Lindquist SL. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 2005; 435:765 - 772
   PubMed Web of Science ®Google Scholar
• Tanaka M, Chien P, Yonekura K, Weissman JS. Mechanism of cross-species prion transmission: An infectious conformation compatible with two highly divergent yeast prion proteins. Cell 2005; 121:49 - 62
   PubMed Web of Science ®Google Scholar
• Song Y, Wu YX, Jung G, Tutar Y, Eisenberg E, Greene LE, Masison DC. Role for Hsp70 chaperone in Saccharomyces cerevisiae prion seed replication. Eukaryot Cell 2005; 4:289 - 297
   PubMed Web of Science ®Google Scholar
• Dagkesamanskaya AR, Ter-Avanesyan MD. Interaction of the yeast omnipotent suppressors SUP1(SUP45) and SUP2(SUP35) with nonMendelian factors. Genetics 1991; 128:513 - 520
   PubMed Web of Science ®Google Scholar
• Salnikova AB, Kryndushkin DS, Smirnov VN, Kushnirov VV, Ter-Avanesyan MD. Nonsense suppression in yeast cells overproducing Sup35 (eRF3) is caused by its nonheritable amyloids. J Biol Chem 2005; 280:8808 - 8812
   PubMed Web of Science ®Google Scholar
• Johan K, Westermark G, Engström U, Gustavsson A, Hultman P, Westermark P. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci USA 1998; 95:2558 - 2563
   PubMed Web of Science ®Google Scholar
• Ghaemmaghami S, Huh WK, Bower K, Howson RW, Belle A, Dephoure N, O'Shea EK, Weissman JS. Global analysis of protein expression in yeast. Nature 2003; 425:737 - 741
   PubMed Web of Science ®Google Scholar
• Klein MA, Frigg R, Flechsig E, Raeber AJ, Kalinke U, Bluethmann H, Bootz F, Suter M, Zinkernagel RM, Aguzzi A. A crucial role for B cells in neuroinvasive scrapie. Nature 1997; 390:687 - 690
   PubMed Web of Science ®Google Scholar
• Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B. The most infectious prion protein particles. Nature 2005; 437:257 - 261
   PubMed Web of Science ®Google Scholar
• Lundmark K, Westermark GT, Nyström S, Murphy CL, Solomon A, Westermark P. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci USA 2002; 99:6979 - 6984
   PubMed Web of Science ®Google Scholar
• Xing Y, Nakamura A, Chiba T, Kogishi K, Matsushita T, Li F, Guo Z, Hosokawa M, Mori M, Higuchi K. Transmission of mouse senile amyloidosis. Lab Invest 2001; 81:493 - 499
   PubMed Web of Science ®Google Scholar